ny stock exchange today

Facebook CEO Mark Zuckerberg

In 2014, Facebook Inc. (Nasdaq: FB) founder Mark Zuckerberg paid close to $100 million for 700 acres of beachfront property on the Hawaiian island of Kauai.

Now the social media multibillionaire is suing hundreds of locals in the area who still have legal ownership claims to parts of his estate through their ancestors.

Which is exactly why Zuckerberg is taking them to court

Mark Zuckerberg Sues Natives for Eight Acres of Land

Three holding companies all of which are controlled by Zuckerberg filed eight lawsuits in local court on Dec. 30, 2016, against families who collectively inherited 14 parcels of land through the Kuleana Act.

This particular legislation was established in 1850 to give – for the first time – island natives the right to own the land on which theyd lived.

ny stock exchange today: Peugeot S.A. (PUGOY)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    Now, the General is thinking about ditching Europe for good by selling its European operations to French automaker Peugeot (NASDAQOTH:PUGOY). As long as Peugeot is willing to pay a reasonable price, selling Opel is GM’s best course of action.

  • [By John Rosevear]

    It’s official: General Motors (NYSE:GM) will sell its long-troubled Opel subsidiary to French automaker Peugeot S.A. (NASDAQOTH:PUGOY) for about $2.3 billion, in a deal expected to close later this year.

  • [By SEEKINGALPHA.COM]

    Yes, you read that correct! General Motors (NYSE: GM) will probably not settle for just a new 52-week high and will aim to take out the 2013 peak of $41.85. With talks about the Opel sellout to PSA Group (OTCPK:PEUGF) (OTCPK:PUGOY) progressing at a rate much faster than I had anticipated, a (likely) deal announcement on Monday will pave the way for new all-time highs.

ny stock exchange today: VALE S.A.(VALE)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Mosaic (MOS) tumbled to the bottom of the S&P 500 today after announcing that it would buy Vale’s (VALE) fertilizer unit.

    Getty Images

    Mosaicdropped 1.1% to $27.77 today, while the S&P 500 advanced 0.2% to 2,262.53.

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian spoke about unusually high put options activity in Arconic Inc (NYSE: ARNC) and Vale SA (ADR) (NYSE: VALE).

ny stock exchange today: FMC Technologies, Inc.(FTI)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Following a series of M&A announcements in the oilfield-services sector since the onset of the oil market downturn, French oil-field service company Technip and U.S. oilfield equipment company FMC Technologies (NYSE:FTI) hooked up in an all-stock deal valuing the combined company at $13 billion. Shareholders of each company will own 50% of the combined entity, to be named TechnipFMC, which implies a roughly $6.5 billion acquisition valuation for each entity. The transaction, which should close early next year, will “combine Technip’s innovative systems and solutions, state-of-the-art assets, engineering strengths, and project management capabilities with FMC Technologies’ leading technology, manufacturing, and service capabilities.” Further, it should save $400 million in annual costs by 2019. Moreover, it will enable the combined company to compete better against larger oil-field service rivals Baker Hughes (NYSE:BHI), Halliburton (NYSE:HAL), and Schlumberger (NYSE:SLB), which have all gained strength during the downturn either through M&A activities or cost savings initiatives.

ny stock exchange today: (SIOLF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    China Life (NYSE:LFC) holds a 44 percent stake in China Guangfa Bank and a 30 percent stake in Sino-Ocean Group (OTCPK:SIOLF). Foresea owns large stakes in Gree Electric Appliances and China Vanke. If they are forced to sell their stakes, the Chinese stock market could see a sudden downturn.

ny stock exchange today: Daiichi Sankyo Company, Limited (DSKYF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    According to Bob Radie (see transcript of January 9th teleconference), the company’s president and chief executive officer, a key consideration in the denial was the FDA’s granting, in November 2016, rival product MorphaBond three-year exclusivity for the intranasal route of abuse. Significantly, though, even though MorphaBond – developed by tiny, privately-owned Inspirion Delivery Technologies – was approved in October 2015, it is yet to be commercialized. An October 25, 2016, marketing agreement between Inspirion and Japan-based Daiichi Sankyo, Inc. (OTCPK:DSKYF) suggests MorphaBond could be launched in the near future, but it’s also important to note that the aforementioned exclusivity expires on October 2, 2018, at which point Egalet will be able to include the clinical data from its intranasal abuse potential study in its label.

Leave a Reply

Your email address will not be published. Required fields are marked *